22 May 2013
Keywords: vanda, shares, halve, iloperidone, setback, pharmaceuticals, lost
Article | 04 August 2008
Shares in Vanda Pharmaceuticals lost half their value after US regulators rejected its schizophrenia drug iloperidone. The Food and
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 August 2008
21 May 2013
© 2013 thepharmaletter.com